Medroxyprogesterone Acetate
NDC 0548-5701, Medroxyprogesterone acetate, injection, suspension, extended release, from Amphastar Pharmaceuticals, Inc..
- Product NDC
- 0548-5701
- Status
- Listed
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077334
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0548-5701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEDROXYPROGESTERONE ACETATE150 mg/mL
Pharmacologic classes
Progesterone Congeners [CS]; Progestin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0548-5701-00 | 00548570100 | 1 SYRINGE in 1 CARTON (0548-5701-00) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fda1aa8a-5739-482a-b4f6-9741ef4d9977NADAC price for package 00548570100
GET /v1/drugs/nadac/00548570100
Use it
Look up 0548-5701 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0548-5701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0548-5701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.